DNA amplifications and aneuploidy, high proliferative activity and impaired cell cycle control characterize breast carcinomas with poor prognosis

Analytical Cellular Pathology

Volumn 25, Issue 3, 2003, Pages 103-114

  Blegen, Harald ^a   Will, John S ^b   Ghadimi, B Michael ^b   Nash, Hesed Padilla ^b   Zetterberg, Anders ^a   Auer, Gert ^a   Ried, Thomas ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Breast cancer; Cell cycle; CGH; Survival

Indexed keywords

CYCLIN A; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN E; KI 67 ANTIGEN; PROTEIN; PROTEIN P53; UNCLASSIFIED DRUG;

ANEUPLOIDY; ARTICLE; BREAST CARCINOMA; CANCER SURVIVAL; CELL CYCLE; CELL PROLIFERATION; CHROMOSOME 11P; CHROMOSOME 11Q; CHROMOSOME 17P; CHROMOSOME 1Q; CHROMOSOME 3Q; CHROMOSOME 4Q; CHROMOSOME 5P; CHROMOSOME 8Q; CHROMOSOME 9P; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME MAP; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MASTECTOMY; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

EID: 0038621256     PISSN: 09218912     EISSN: None     Source Type: Journal    
DOI: 10.1155/2003/491362     Document Type: Article

References (42)

1. M. Barlund, M. Tirkkonen, F. Forozan, M.M. Tanner, O. Kallioniemi and A. Kallioniemi, Increased copy number at 17q22-q24 by CGH in breast cancer is due to high-level amplification of two separate regions, Genes Chromosomes Cancer 20(4) (1997), 372-376.
2. I. Bieche, M.H. Champeme, F. Matifas, K. Hacene, R. Callahan and R. Lidereau, Loss of heterozygosity on chromosome 7q and aggressive primary breast cancer, Lancet 339(8786) (1992), 139-143.
3. I.R. Bukholm, G. Bukholm and J.M. Nesland, Over-expression of cyclin A is highly associated with early relapse and reduced survival in patients with primary breast carcinomas, Int. J. Cancer 93(2) (2001), 283-287.
4. I.R. Bukholm, G. Bukholm and J.M. Nesland, Coexpression of cyclin A and beta-catenin and survival in breast cancer patients, Int. J. Cancer 94(1) (2001), 148-149.
5. M.H. Champeme, I. Bieche, S. Lizard and R. Lidereau, 11q13 amplification in local recurrence of human primary breast cancer, Genes Chromosomes Cancer 12(2) (1995), 128-133.
6. M.A. Chaudary, D. Tong, R. Millis, P. Smith, I.S. Fentiman and R.D. Rubens, Loco-regional recurrence following mastectomy for early breast carcinoma: efficacy of radiotherapy at the time of recurrence, Eur. J. Surg. Oncol. 23(4) (1997), 348-353.
7. F. Courjal, G. Louason, P. Speiser, D. Katsaros, R. Zeillinger and C. Theillet, Cyclin gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors, Int. J. Cancer 69(4) (1996), 247-253.
8. J. Cuzick, H. Stewart, L. Rutqvist, J. Houghton, R. Edwards, C. Redmond, R. Peto, M. Baum, B. Fisher, H. Host et al., Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy, J. Clin. Oncol. 12(3) (1994), 447-453.
9. G. Deng, Y. Lu, G. Zlotnikov, A.D. Thor and H.S. Smith, Loss of heterozygosity in normal tissue adjacent to breast carcinomas, Science 274(5295) (1996), 2057-2059.
10. W.S. el-Deiry, J.W. Harper, P.M. O'Connor, V.E. Velculescu, C.E. Canman, J. Jackman, J.A. Pietenpol, M. Burrell, D.E. Hill, Y. Wang et al., WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis, Cancer Res. 54(5) (1994), 1169-1174.
11. C.W. Elston and I.O. Ellis, Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up, Histopathology 19 (1991), 403-410, Histopathology 41(3A) (2002), 151.
12. C.W. Elston and I.O. Ellis, Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up, Histopathology 19 (1991), 403-410, Histopathology 41(3A) (2002), 151.
13. E.R. Fearon and B. Vogelstein, A genetic model for colorectal tumorigenesis, Cell 61(5) (1990), 759-767.
14. K. Fukasawa, F. Wiener, G.F. Vande Woude and S. Mai, Genomic instability and apoptosis are frequent in p53 deficient young mice, Oncogene 15(11) (1997), 1295-1302.
15. K. Fukasawa, T. Choi, R. Kuriyama, S. Rulong and G.F. Vande Woude, Abnormal centrosome amplification in the absence of p53, Science 271(5256) (1996), 1744-1747.
16. X.Y. Guan, P.S. Meltzer, W.S. Dalton and J.M. Trent, Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissection, Nat. Genet. 8(2) (1994), 155-161.
17. P.J. Hainsworth, K.L. Raphael, R.G. Stillwell, R.C. Bennett and O.M. Garson, Rearrangement of chromosome 1p in breast cancer correlates with poor prognostic features, Br. J. Cancer 66(1) (1992), 131-135.
18. L. Hartwell, T. Weinert, L. Kadyk and B. Garvik, Cell cycle checkpoints, genomic integrity, and cancer, Cold Spring Harb. Symp. Quant. Biol. 59 (1994), 259-263.
19. L. Hartwell, Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells, Cell 71(4) (1992), 543-546.
20. J.L. Haybittle, D. Brinkley, J. Houghton, R.P. A'Hern and M. Baum, Postoperative radiotherapy and late mortality: evidence from the Cancer Research Campaign trial for early breast cancer, BMJ 298(6688) (1989), 1611-1614.
21. S. Heim and F. Mitelman, Cancer Cytogenetics, Wiley-Liss, 1995.
22. K. Heselmeyer, E. Schrock, S. du Manoir, H. Blegen, K. Shah, R. Steinbeck, G. Auer and T. Ried, Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix, Proc. Natl. Acad. Sci. USA 93(1) (1996), 479-484.
23. J.J. Isola, O.P. Kallioniemi, L.W. Chu, S.A. Fuqua, S.G. Hilsenbeck, C.K. Osborne and F.M. Waldman, Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer, Am. J. Pathol. 147(4) (1995), 905-911.
24. T. Jansson, M. Inganas, S. Sjogren, T. Norberg, A. Lindgren, L. Holmberg and J. Bergh, p53 Status predicts survival in breast cancer patients treated with or without postoperative radiotherapy: a novel hypothesis based on clinical findings, J. Clin. Oncol. 13(11) (1995), 2745-2751.
25. T. Kuukasjarvi, M. Tanner, S. Pennanen, R. Karhu, O.P. Kallioniemi and J. Isola, Genetic changes in intraductal breast cancer detected by comparative genomic hybridization, Am. J. Pathol. 150(4) (1997), 1465-1471.
26. F. Linell and F. Rank. Breast cancer. Comments on histologic classifications with reference to histogenesis and prognosis, Universitetsförlaget Dialogos, Lund, 1989.
27. M. Loda, B. Cukor, S.W. Tam, P. Lavin, M. Fiorentino, G.F. Draetta, J.M. Jessup and M. Pagano, Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas, Nat. Med. 3(2) (1997), 231-234.
28. E.W. Newcomb, M. Sosnow, R.I. Demopoulos, A. Zeleniuch-Jacquotte, J. Sorich and J.L. Speyer, Expression of the cell cycle inhibitor p27KIP1 is a new prognostic marker associated with survival in epithelial ovarian tumors, Am. J. Pathol. 154(1) (1999), 119-125.
29. T. Norberg, T. Jansson, S. Sjogren, C. Martensson, I. Andreasson, M.L. Fjallskog, H. Lindman, H. Nordgren, A. Lindgren, L. Holmberg and J. Bergh, Overview on human breast cancer with focus on prognostic and predictive factors with special attention on the tumour suppressor gene p53, Acta Oncol. 35(Suppl. 5) (1996), 96-102.
30. N. Pandis, S. Heim, G. Bardi, I. Idvall, N. Mandahl and F. Mitelman, Chromosome analysis of 20 breast carcinomas: cytogenetic multiclonality and karyotypic-pathologic correlations, Genes Chromosomes Cancer 6(1) (1993), 51-57.
31. A.G. Paulovich, D.P. Toczyski and L.H. Hartwell, When checkpoints fail, Cell 88(3) (1997), 315-321.
32. P.L. Porter, K.E. Malone, P.J. Heagerty, G.M. Alexander, L.A. Gatti, E.J. Firpo, J.R. Daling and J.M. Roberts, Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients, Nat. Med. 3(2) (1997), 222-225.
33. T. Ried, K. Heselmeyer-Haddad, H. Blegen, E. Schrock and G. Auer, Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: a phenotype/genotype correlation, Genes Chromosomes Cancer 25(3) (1999), 195-204.
34. T. Ried, R. Knutzen, R. Steinbeck, H. Blegen, E. Schrock, K. Heselmeyer, S. du Manoir and G. Auer, Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors, Genes Chromosomes Cancer 15(4) (1996), 234-245.
35. D.J. Slamon, W. Godolphin, L.A. Jones, J.A. Holt, S.G. Wong, D.E. Keith, W.J. Levin, S.G. Stuart, J. Udove, A. Ullrich et al., Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer, Science 244(4905) (1989), 707-712.
36. M.L. Smith and A.J. Fornace, Jr., Genomic instability and the role of p53 mutations in cancer cells, Curr. Opin. Oncol. 7(1) (1995), 69-75.
37. G. Sonoda, S. du Manoir, A.K. Godwin, D.W. Bell, Z. Liu, M. Hogan, M. Yakushiji and J.R. Testa, Detection of DNA gains and losses in primary endometrial carcinomas by comparative genomic hybridization, Genes Chromosomes Cancer 18(2) (1997), 115-125.
38. R.G. Steinbeck, The DNA content of chromosome division figures and interphase nuclei classifies ulcerative colitis, Eur. J. Cancer 34(1) (1998), 175-181.
39. P. Tan, B. Cady, M. Wanner, P. Worland, B. Cukor, C. Magi-Galluzzi, P. Lavin, G. Draetta, M. Pagano and M. Loda, The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas, Cancer Res. 57(7) (1997), 1259-1263.
40. M.M. Tanner, M. Tirkkonen, A. Kallioniemi, K. Holli, C. Collins, D. Kowbel, J.W. Gray, O.P. Kallioniemi and J. Isola, Amplification of chromosomal region 20q13 in invasive breast cancer: prognostic implications, Clin. Cancer Res. 1(12) (1995), 1455-1461.
41. H. Tsuda, D.F. Callen, T. Fukutomi, Y. Nakamura and S. Hirohashi, Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancers irrespectively of differences in phenotype and extent of spread, Cancer Res. 54(2) (1994), 513-517.
42. M.L. Yaremko, W.M. Recant and C.A. Westbrook, Loss of heterozygosity from the short arm of chromosome 8 is an early event in breast cancers, Genes Chromosomes Cancer 13(3) (1995), 186-191.